Mortality Benefit with Prasugrel in the TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk-Adjusted Retrospective Data Analysis

OBJECTIVES: The objective of this study is to characterize the bleeding, transfusion and other outcomes of patients related to the timing of prasugrel or clopidogrel withdrawal prior to coronary artery bypass grafting (CABG). BACKGROUND: There is little evidence to guide clinical decision making reg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, Peter K, Goodnough, Lawrence T, Levy, Jerrold H, Poston, Robert S, Short, Mary A, Weerakkody, Govinda J, LeNarz, LeRoy A
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407327/
https://ncbi.nlm.nih.gov/pubmed/22633653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.03.030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars